River Road Asset Management LLC purchased a new stake in Orthofix International N.V. (NASDAQ:OFIX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 138,096 shares of the medical device company’s stock, valued at approximately $6,419,000. River Road Asset Management LLC owned approximately 0.77% of Orthofix International N.V. as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Texas Permanent School Fund bought a new stake in Orthofix International N.V. during the first quarter valued at $355,000. Karp Capital Management Corp bought a new stake in Orthofix International N.V. during the first quarter valued at $474,000. Gabelli Funds LLC increased its stake in Orthofix International N.V. by 0.3% in the first quarter. Gabelli Funds LLC now owns 291,450 shares of the medical device company’s stock valued at $11,119,000 after buying an additional 1,000 shares during the last quarter. UBS Asset Management Americas Inc. bought a new stake in Orthofix International N.V. during the first quarter valued at $229,000. Finally, Comerica Bank bought a new stake in Orthofix International N.V. during the first quarter valued at $783,000. Institutional investors own 94.43% of the company’s stock.

Shares of Orthofix International N.V. (NASDAQ:OFIX) opened at 48.06 on Wednesday. The firm’s 50-day moving average price is $46.23 and its 200 day moving average price is $41.75. Orthofix International N.V. has a 52 week low of $32.51 and a 52 week high of $49.60. The stock has a market capitalization of $873.25 million, a P/E ratio of 112.55 and a beta of 0.25.

Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings data on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The business had revenue of $108.90 million for the quarter, compared to analyst estimates of $102.94 million. During the same period last year, the business earned $0.41 EPS. The company’s revenue was up 4.6% on a year-over-year basis. Analysts expect that Orthofix International N.V. will post $1.57 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/08/30/138096-shares-in-orthofix-international-n-v-ofix-acquired-by-river-road-asset-management-llc.html.

Several research firms recently weighed in on OFIX. BidaskClub upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Jefferies Group LLC restated a “buy” rating and issued a $55.00 price target (up previously from $50.00) on shares of Orthofix International N.V. in a research note on Thursday, August 10th. TheStreet upgraded Orthofix International N.V. from a “c+” rating to a “b-” rating in a research note on Tuesday, August 8th. Zacks Investment Research upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a research note on Thursday, August 10th. Finally, BTIG Research began coverage on Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price target on the stock. Seven analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and an average target price of $52.75.

In related news, insider Raymond Fujikawa sold 6,364 shares of Orthofix International N.V. stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $47.06, for a total transaction of $299,489.84. Following the sale, the insider now directly owns 31,084 shares in the company, valued at approximately $1,462,813.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Brad Mason sold 2,733 shares of Orthofix International N.V. stock in a transaction on Monday, August 21st. The stock was sold at an average price of $48.10, for a total transaction of $131,457.30. Following the sale, the chief executive officer now owns 188,053 shares in the company, valued at $9,045,349.30. The disclosure for this sale can be found here. 5.60% of the stock is currently owned by company insiders.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Stock Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related stocks with our FREE daily email newsletter.